Luteal and hypophyseal expression of the canine relaxin (RLN) system during pregnancy: Implications for luteotropic function

PLoS One. 2018 Jan 24;13(1):e0191374. doi: 10.1371/journal.pone.0191374. eCollection 2018.

Abstract

By acting through its receptors (RXFP1, RXFP2), relaxin (RLN) exerts species-specific effects during pregnancy; possible luteotropic effects through stimulation of prolactin (PRL) release have been suggested. In the domestic dog (Canis lupus familiaris) serum PRL increases in pregnant bitches shortly after RLN appears in the circulation, and a possible functional relationship between the RLN and the PRL systems in regulating progesterone secretion has been implied. Therefore, here (Study 1) the luteal expression and localization of the RLN system was investigated by immunohistochemistry using custom-made antibodies and semi-quantitative PCR, at selected time points during gestation: pre-implantation (d. 8-12), post-implantation (d. 18-25), mid-gestation (d. 35-40) and at normal and antigestagen-induced luteolysis. Further, (Study 2) hypophyseal expression of the RLN system and its spatial association with PRL was assessed. Luteal expression of RLN, but not of its receptors, was time-dependent: it increased significantly following implantation towards mid-gestation and decreased at prepartum. Antigestagen treatment resulted in downregulation of RLN and RXFP2. Whereas RLN was localized in steroidogenic cells, RXFP1 and RXFP2 also stained strongly in macrophages and vascular endothelial cells. The RLN system was detected in the canine adenohypophysis and was co-localized with PRL in hypophyseal lactotrophs. The intraluteal RLN seems to be involved in regulating the canine corpus luteum (CL) in a time-dependent manner. The presence of RLN family members in the adenohypophysis implies their possible involvement in regulating the availability of PRL and other pituitary hormones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Corpus Luteum / physiology*
  • Corpus Luteum Maintenance / genetics
  • Corpus Luteum Maintenance / physiology
  • Dogs
  • Estrenes / pharmacology
  • Female
  • Gene Expression / drug effects
  • Immunohistochemistry
  • Models, Biological
  • Pituitary Gland / physiology*
  • Pregnancy
  • Prolactin / blood
  • Prolactin / physiology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Real-Time Polymerase Chain Reaction
  • Receptors, G-Protein-Coupled / genetics
  • Receptors, G-Protein-Coupled / physiology
  • Receptors, Peptide / genetics
  • Receptors, Peptide / physiology
  • Relaxin / blood
  • Relaxin / genetics
  • Relaxin / physiology*
  • Species Specificity

Substances

  • Estrenes
  • RNA, Messenger
  • Receptors, G-Protein-Coupled
  • Receptors, Peptide
  • relaxin receptors
  • aglepristone
  • Prolactin
  • Relaxin

Grants and funding

The project was supported by the Swiss National Science Foundation (SNSF), grant no. 31003A_160251 to MPK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.